# Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

> **NCT00830115** · — · COMPLETED · sponsor: **Nycomed** · enrollment: 1045 (actual)

## Conditions studied

- Sleep Disorders
- Non-Erosive Reflux Disease
- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT00830115
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 1045 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830115, "Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00830115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*